生物帮生物通

采购帮忙热线
020-87540820
020-38498013
 
当前位置: 首页 » 行业资讯 » 行业资讯 » 正文

DNA云数据库企业DNAnexus获1500万美元C轮融资

放大字体  缩小字体 发布日期:2014-01-06  浏览次数:3

美国DNAnexus


2014年1月3日 为大规模DNA数据管理及分析提供云解决方案的DNAnexus宣布获得了1500万美元的C轮融资。

DNAnexus是一家为生物信息技术提供云解决方案的初创企业。其具有成本效益的DNA测序平台即服务(PaaS)解决方案足以对企业级产品构成挑战,迅速吸引了许多客户的采用。

这种解决方案是通过将DNA数据集中放到云端进行管理,同时利用共享工具,通过访问不同的参照数据集(包括基因型数据和表型数据)并与科学家展开协作来加快基础科学与临床突破。平台为各种实验室提供了一种安全、合规的云平台,可支持规模不受限制的计算机存储资源。

最近DNAnexus还分别与斯坦福大学与贝勒医学院合作推出了一个大型项目以展示该平台对于大规模基因数据处理的价值。在这两个项目里,DNAnexus共处理了17000个基因组,生成的基因数组超过500TB。所生成数据可在平台上访问供后续分析与数据共享使用。

此轮融资由Claremont Creek Ventures、Google Ventures等领投,所得融资将用于扩展平台能力以便支撑数量不断增长的商业及学术性实验室客户。

 

 

DNAnexus Secures $15 Million in Series C Financing to Accelerate Commercialization of Its Enterprise Platform for DNA Sequencing Data

Funding led by Claremont Creek Ventures, Google Ventures, TPG Biotech, and First Round Capital

 

January 03, 2014 08:00 AM Eastern Standard Time

MOUNTAIN VIEW, Calif.--()--DNAnexus, a pioneer in cloud-based solutions for large-scale DNA data management and analysis, today announced that it has closed a $15 million Series C funding led by Claremont Creek Ventures, Google Ventures, TPG Biotech, and First Round Capital. The company’s innovative Platform-as-a-Service (PaaS), is experiencing rapid customer adoption and delivers a cost-effective solution to the challenges that global enterprises face when building clinically compliant analysis pipelines for DNA sequence data.

“The next wave of insights in genetics comes from multi-institutional collaborative efforts producing huge amounts of data. DNAnexus has created a system where large enterprises, laboratories, and individuals can collaborate more efficiently using modern cloud technologies”

DNAnexus was designed to accelerate basic science and clinical breakthroughs by providing a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The platform provides labs of any size a secure and compliant cloud platform that supports the unlimited scaling of computational and storage resources. Through DNAnexus, global collaborators can connect effortlessly, while remaining compliant with HIPAA, CLIA, and international regulatory requirements.

Richard Daly, CEO of DNAnexus, commented: “This is an exciting time of growth for DNAnexus. This funding will significantly expand our capacity to support the growing number of commercial and academic labs around the world utilizing our platform to manage DNA data and analyses in a clinically appropriate manner. We welcome Claremont Creek Ventures to the team and are pleased with the continued support from Google Ventures, TPG Biotech, and First Round Capital.”

Recently, DNAnexus announced large-scale projects with Stanford University and Baylor College of Medicine that demonstrate the value of the company’s platform in processing tens of thousands of genomes and making the resulting data sets securely available to researchers around the world. Through these two projects alone, DNAnexus processed over 17,000 genomes and generated more than 500 terabytes of genomic data. The resulting data sets can be accessed on DNAnexus and are available for follow-on analysis and data sharing to researchers participating in the 1000 Genomes Project and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Nat Goldhaber, Managing Director at Claremont Creek Ventures and new DNAnexus Board Member added, “We are thrilled to support an important computational tool that will accelerate the critical transition from pure research to ubiquitous clinical application.”

“The next wave of insights in genetics comes from multi-institutional collaborative efforts producing huge amounts of data. DNAnexus has created a system where large enterprises, laboratories, and individuals can collaborate more efficiently using modern cloud technologies,” said Krishna Yeshwant, Google Ventures General Partner and DNAnexus Board Member. “DNAnexus is changing how global biomedical research and development markets manage DNA data and analytic infrastructures.”

About DNAnexus

DNAnexus is powering the genomics revolution with an enterprise-level solution that combines cloud computing with advanced bioinformatics. The DNAnexus team is made up of experts in software, computational biology, and genetics who are on a mission to establish DNAnexus at the center of a growing ecosystem of scientific and clinical research, and diagnostic efforts in personalized medicine. For more information please visit: https://dnanexus.com.

 

Contacts

for DNAnexus
Colin Sanford, 203-340-2441
colin@bioscribe.com

 
 
[ 行业资讯搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

0条 [查看全部]  相关评论

 
推荐行业资讯
点击排行
 
网站首页 | 企业资料认证流程 | 广告服务 | 关于我们 | 联系方式 | 使用协议 | 网站地图 | 排名推广 | 广告服务 | 网站留言 | RSS订阅 | 粤ICP备11050685号-8